- Home
- CADL vs INFU Comparison
CADL vs INFU Comparison
Compare CADL & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- INFU
- Stock Information
- Founded
- CADL 1999
- INFU 2005
- Country
- CADL United States
- INFU United States
- Employees
- CADL N/A
- INFU N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- INFU Medical/Dental Instruments
- Sector
- CADL Health Care
- INFU Health Care
- Exchange
- CADL Nasdaq
- INFU Nasdaq
- Market Cap
- CADL 159.1M
- INFU 189.2M
- IPO Year
- CADL 2021
- INFU N/A
- Fundamental
- Price
- CADL $6.67
- INFU $7.98
- Analyst Decision
- CADL Strong Buy
- INFU
- Analyst Count
- CADL 1
- INFU 0
- Target Price
- CADL $19.00
- INFU N/A
- AVG Volume (30 Days)
- CADL 2.6M
- INFU 65.5K
- Earning Date
- CADL 11-14-2024
- INFU 03-13-2025
- Dividend Yield
- CADL N/A
- INFU N/A
- EPS Growth
- CADL N/A
- INFU 60.96
- EPS
- CADL N/A
- INFU 0.07
- Revenue
- CADL N/A
- INFU $132,783,999.00
- Revenue This Year
- CADL N/A
- INFU $10.23
- Revenue Next Year
- CADL N/A
- INFU $8.80
- P/E Ratio
- CADL N/A
- INFU $114.28
- Revenue Growth
- CADL N/A
- INFU 8.17
- 52 Week Low
- CADL $1.16
- INFU $5.74
- 52 Week High
- CADL $14.60
- INFU $10.03
- Technical
- Relative Strength Index (RSI)
- CADL 43.36
- INFU 45.87
- Support Level
- CADL $6.83
- INFU $7.42
- Resistance Level
- CADL $8.08
- INFU $8.15
- Average True Range (ATR)
- CADL 0.85
- INFU 0.35
- MACD
- CADL -0.30
- INFU -0.01
- Stochastic Oscillator
- CADL 0.47
- INFU 40.58
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair.